BiotechTube

gammaglobulin

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Common Variable Immunodeficiency

Conditions

Common Variable Immunodeficiency, Agammaglobulinemia

Trial Timeline

Jan 1, 2002 → Nov 1, 2002

NCT ID
NCT00661401

About gammaglobulin

gammaglobulin is a pre-clinical stage product being developed by CSL for Common Variable Immunodeficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00661401. Target conditions include Common Variable Immunodeficiency, Agammaglobulinemia.

What happened to similar drugs?

5 of 17 similar drugs in Common Variable Immunodeficiency were approved

Approved (5) Terminated (3) Active (10)
✅Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
✅Dextromethorphan + PlaceboNovartisApproved
✅VivaglobinCSLApproved
✅Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + PlaceboBayerApproved
✅Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved
🔄Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
🔄XylometazolineNovartisPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00661401Pre-clinicalCompleted

Competing Products

20 competing products in Common Variable Immunodeficiency

See all competitors
ProductCompanyStageHype Score
Nasal Glucagon + OxymetazolineEli LillyPhase 1
29
New Formulation Phenylephrine HCl + Marketed Phenylephrine HCl + PlaceboJohnson & JohnsonPhase 2
27
Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
43
Zostavax®MerckPre-clinical
18
Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
40
CDZ173NovartisPhase 2/3
38
Dextromethorphan + PlaceboNovartisApproved
35
XylometazolineNovartisPhase 3
40
N-acetylcysteine + PlaceboNovartisPhase 2
35
Advil Congestion Relief + Advil Allergy and Congestion Relief + ParacetamolPfizerPhase 3
32
pseudoephedrine hydrochloride 30 mg tablets + Placebo tabletsPfizerPhase 3
40
Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)CSLPhase 3
40
VivaglobinCSLApproved
43
Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + PlaceboBayerApproved
40
Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved
40
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain + Acetylsalicylic Acid (Aspirin, BAYE4465) + Lidocain + PlaceboBayerPhase 3
37
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + PlaceboBayerPhase 3
37
Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + PlaceboBayerPhase 3
37
Acetylcysteine + Paracetamol + PhenylephrineSandoz GroupPhase 3
29
A-101Aclaris TherapeuticsPhase 3
30